Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q1 2026: Merck & Co. 16.286, Sanofi 13.284.
Merck & Co. vs Sanofi Net Worth and Market Cap
Merck & Co. (MRK) and Sanofi (SNY) are peers in Vaccines. Merck & Co. reported revenue of $16.3B as of Q1 2026, compared with $13.3B for Sanofi. Merck & Co. leads on revenue.
Merck & Co.'s gross margin is 81.9% versus 75.5% for Sanofi. Merck & Co.'s net margin is -26.0% versus 2.8% for Sanofi.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Merck & Co., Sanofi.| Metric | Merck & Co. | Sanofi |
|---|---|---|
| Market Cap | - | - |
| Revenue | $16.29B | $13.28B |
| Cost of Revenue | $2.94B | $3.26B |
| Gross Profit | $13.34B | $10.03B |
| Operating Income | $-1.88B | $2.58B |
| Net Income | $-4.24B | $370.00M |
| R&D Expense | $12.56B | $2.41B |
| Earnings Per Share | -$1.72 | $0.15 |
| Gross Margin | 81.9% | 75.5% |
| Operating Margin | -11.6% | 19.4% |
| Net Profit Margin | -26.0% | 2.8% |
| Free Cash Flow | $2.93B | $4.22B |
| Cumulative Free Cash Flow | $245.22B | $51.81B |
| Operating Cash Flow | $3.92B | $5.85B |
| Cash & Equivalents | $5.33B | $6.86B |
Prefer Sterling in Google
Add sterlingcharts.com as a preferred source so our charts can appear with a preferred badge in Google Top Stories, AI Mode, and AI Overviews.